Alembic Pharmaceuticals LimitedNSE: APLLTD

Press Release Oct 03 2024

· Issued by Alembic Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-oct-03-2024-8

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 03, 2024, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Alcaftadine Ophthalmic Solution, 0.25% (OTC)".

View Attachment

6ix hasn’t read this filing yet.

Alembic Pharmaceuticals Limited on 6ix

Earlier from Alembic Pharmaceuticals

Later from Alembic Pharmaceuticals

All Alembic Pharmaceuticals news releases